ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ProPhase Labs's enterprise value was $99.68K on Oct 19, 2026, against $14.45M a year earlier. Over the last 5 years it ranged from $99.68K to $160.69M, with a median of $62.46M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $99.68K | -92.8% |
| 2025 | Dec 31, 2025 | $1.39M | -91.4% |
| 2024 | Dec 31, 2024 | $16.15M | -78.7% |
| 2023 | Dec 29, 2023 | $75.67M | -38.4% |
| 2022 | Dec 30, 2022 | $122.88M | +42.8% |
| 2021 | Dec 31, 2021 | $86.04M | +32.5% |
| 2020 | Dec 31, 2020 | $64.96M | +303.6% |
| 2019 | Jan 31, 2019 | $16.10M | -4.9% |
| 2018 | Dec 31, 2018 | $16.92M | – |
| 2017 | Dec 29, 2017 | -$336.72K | -110.4% |
| 2016 | Jan 29, 2016 | $3.24M | -24.5% |
| 2015 | Dec 31, 2015 | $4.29M | -81.4% |
| 2014 | Jan 31, 2014 | $23.03M | +29.8% |
| 2013 | Dec 31, 2013 | $17.74M | – |
See a number that looks wrong?